Coeptis Therapeutics, Inc.
COEP
FAIR PRICE VALUATION
Updated daily
Model: DCF 50% · Relative 30% · Consensus 20%
MARKET PRICE
$11.06
FAIR PRICE
$5.94
MARGIN
$5.12
P/E Ratio
N/A
Div. Yield
N/A
ROE
-123.5%
Market Cap
$40M
Small-cap
COMING SOON
Get notified when COEP's fair price changes
Fair Price Index app is launching soon with push notifications when valuations shift for stocks you follow.
iOS and Android · Free tier available
KEY FACTS
CEO
David Mehalick
COUNTRY
US
HEADQUARTERS
Wexford
SECTOR
Healthcare
EXCHANGE
NASDAQ
METHODOLOGY
How we calculate COEP's fair price
Coeptis Therapeutics, Inc.'s fair price of $5.94 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%). At the current market price of $11.06, COEP trades 46.3% above its calculated fair value.
DCF MODEL · 50%
Discounted cash flow analysis based on projected free cash flows, discounted at a rate reflecting COEP's risk profile.
RELATIVE · 30%
Comparing COEP's valuation multiples against Healthcare peers.
ANALYST · 20%
Aggregated analyst price targets for COEP, weighted by recency and analyst accuracy.
POWERED BY BULIOS
Get full analysis, financials, and AI insights for COEP.
Explore on BuliosFAQ
What is the fair price of COEP?+
Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for Coeptis Therapeutics, Inc. is $5.94. At the current market price of $11.06, COEP trades 46.3% above its calculated fair value.
Is COEP overvalued or undervalued?+
Coeptis Therapeutics, Inc. is currently overvalued based on our valuation model. The stock trades at $11.06, which is 46.3% above the fair price of $5.94.
How often is COEP's fair price updated?+
We update fair price calculations for COEP daily after market close. The current fair price of $5.94 incorporates the latest market data and sector multiples.
What factors affect COEP's fair price calculation?+
COEP's fair price of $5.94 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight)., ROE of -123.5%.
Is COEP a good buy right now?+
At $11.06, COEP trades 46.3% above our fair value estimate of $5.94. The stock is currently overvalued. ROE stands at -123.5% (average). Fair Price Index provides valuation data — always do your own research before investing.
Does COEP pay dividends?+
COEP does not currently pay a dividend.